NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $3.1 million in its fourth quarter.
On a per-share basis, the Newark, California-based company said it had a loss of 15 cents.
The biopharmaceutical company posted revenue of $11.3 million in the period.
For the year, the company reported that its loss narrowed to $37 million, or $2.09 per share. Revenue was reported as $20.1 million.
Protagonist Therapeutics shares have increased slightly since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $20.89, a climb of 55 percent in the last 12 months.